CLINACCEL ACCELERATING CLINICAL INNOVATION Trademark

Trademark Overview

On Monday, September 3, 2012, a trademark application was filed for CLINACCEL ACCELERATING CLINICAL INNOVATION with the United States Patent and Trademark Office. The USPTO has given the CLINACCEL ACCELERATING CLINICAL INNOVATION trademark a serial number of 85719284. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, November 19, 2021. This trademark is owned by Clinaccel, LLC. The CLINACCEL ACCELERATING CLINICAL INNOVATION trademark is filed in the Advertising, Business and Retail Services category with the following description:

Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval
clinaccel accelerating clinical innovation

General Information

Serial Number85719284
Word MarkCLINACCEL ACCELERATING CLINICAL INNOVATION
Filing DateMonday, September 3, 2012
Status710 - CANCELLED - SECTION 8
Status DateFriday, November 19, 2021
Registration Number4700210
Registration DateTuesday, March 10, 2015
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 29, 2014

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Description of MarkThe mark consists of the term "ClinAccel" alongside a dotted cube design and above the slogan "Accelerating Clinical Innovation".
Goods and ServicesBusiness consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval
Pseudo MarkCLINICAL ACCELERATION ACCELERATING CLINICAL INNOVATION

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, November 19, 2021
Primary Code035
First Use Anywhere DateWednesday, August 1, 2012
First Use In Commerce DateSaturday, June 1, 2013

Trademark Owner History

Party NameClinaccel, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressJacksonville, FL 32258
Party NameClinaccel, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressJacksonville, FL 32258
Party NameClinaccel, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressJacksonville, FL 32258

Trademark Events

Event DateEvent Description
Friday, November 19, 2021CANCELLED SEC. 8 (6-YR)
Tuesday, March 10, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, March 10, 2015REGISTERED-PRINCIPAL REGISTER
Thursday, February 5, 2015NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, February 4, 2015ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, January 21, 2015STATEMENT OF USE PROCESSING COMPLETE
Monday, December 8, 2014USE AMENDMENT FILED
Tuesday, January 20, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, December 8, 2014TEAS STATEMENT OF USE RECEIVED
Tuesday, June 24, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 29, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 29, 2014PUBLISHED FOR OPPOSITION
Wednesday, April 9, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, March 21, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, March 14, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 12, 2014ASSIGNED TO EXAMINER
Wednesday, March 12, 2014PREVIOUS ALLOWANCE COUNT WITHDRAWN
Wednesday, March 12, 2014ASSIGNED TO EXAMINER
Wednesday, March 12, 2014ASSIGNED TO EXAMINER
Wednesday, March 12, 2014ASSIGNED TO EXAMINER
Tuesday, February 4, 2014ASSIGNED TO EXAMINER
Thursday, January 30, 2014WITHDRAWN FROM PUB OTQR REQUEST
Friday, January 17, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, January 10, 2014ASSIGNED TO LIE
Monday, January 6, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, January 6, 2014ASSIGNED TO LIE
Tuesday, December 10, 2013TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, September 24, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, September 24, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, June 10, 2013NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, June 10, 2013FINAL REFUSAL E-MAILED
Monday, June 10, 2013FINAL REFUSAL WRITTEN
Monday, May 20, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, May 18, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, May 18, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 27, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, December 27, 2012NON-FINAL ACTION E-MAILED
Thursday, December 27, 2012NON-FINAL ACTION WRITTEN
Thursday, December 27, 2012ASSIGNED TO EXAMINER
Tuesday, September 11, 2012NOTICE OF DESIGN SEARCH CODE MAILED
Monday, September 10, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, September 6, 2012NEW APPLICATION ENTERED IN TRAM

Related Keywords

innovation clinical accelerating clinaccel management trials assist companies biotechnology them research approval biopharmaceutical